Avizorex Pharma, S.L.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome (NCT03162094) | Avizorex Pharma, S.L. | 2017-04-03 |
Track Avizorex Pharma, S.L. automatically
Every clearance here is in the API, with alerts when new ones post.